| a. |
is
frequently due to genital tract malignancy |
|
| b. |
may
be due to bladder pathology |
|
| c. |
should
always be investigated |
|
| d. |
is
not associated with ovarian cancer |
|
| e. |
is
often to due to cervical ‘erosions’ |
|
| f. |
is more likely
in a patient on anticoagulation |
|
| g. |
is more likely
in a patient on Tamoxifen |
|
| h. |
is more likely
in a patient on steroids |
|
| i. |
is more likely
in a patient on beta-blockers |
|
| j. |
is more likely
in a patient with CIN |
|
| k. |
initial
investigation should include pelvic examination, cervical cytology and a
transvaginal scan |
|